Neuronal GLP1R mediates liraglutide's anorectic but not glucose-lowering effect - PubMed

Glucose control and weight loss are cornerstones of type 2 diabetes treatment. Currently, only glucagon-like peptide-1 (GLP1) analogs are able to achieve both weight loss and glucose tolerance. Both glucose and body weight are regulated by the brain, which contains GLP1 receptors (GLP1R). Even thoug …

https://pubmed.ncbi.nlm.nih.gov/24762441/